CDXS
Codexis, Inc.
stockNASDAQ
codexis, inc. is a leading protein engineering company applying innovative technologies to unlock the power of proteins™. our proprietary codeevolver® technology platform enables the rapid development and production of highly optimized proteins, custom-designed for your application. codexis' revolutionary approach to protein engineering starts with an understanding of the desired performance specifications and optimizes a protein specifically to fit these requirements. you get precisely the protein you need for the job you want it to do. guided by proprietary artificial intelligence software and advanced high-throughput screening systems, codexis is able to efficiently generate and introduce function-driven mutations to rapidly improve a protein for its target application. since 2002, codexis' in-house biochemists, biologists and bioinformatics experts have worked closely with our clients to advance the technologies for protein optimization and production, enabling breakthrough develop
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 1.19 | 2026-10-30 | -8.40% | 1.021 |
| 1M | 1.36 | 2026-10-06 | -19.85% | 1.598 |
| 3M | 1.48 | 2026-08-06 | -26.35% | 1.468 |
| 6M | 2.66 | 2026-05-06 | -59.02% | 1.498 |
| 1Y | 2.04 | 2025-11-06 | -46.44% | 1.724 |
| 2Y | 4.01 | 2024-11-06 | -72.82% | — |
| 5Y | 40.17 | 2021-11-05 | -97.29% | 1.957 |
Codexis, Inc. (NASDAQ:CDXS) stock price today is $1.09, and today's volume is 400,317. CDXS is up 6.863% today. The 30 day average volume is 822,010. CDXS market cap is $119.36M with 109.51M shares outstanding.